A team led by Prof. Michael Cima is developing an implantable sensor that can monitor a tumor’s response to cancer drugs, writes Eric Levenson for Boston.com. “The sensor would function like a long-term medical biopsy, giving doctors a continuous look at how a tumor is developing,” Levenson explains.
Jamie Ducharme writes for Boston Magazine that MIT researchers are developing a biochemical sensor that could provide updates on cancerous tumors. The sensor “could be implanted in cancerous tissue during a patient’s first biopsy. After that, it would stay in the tissue and transmit data about the state of the tumor to an external device.”
Jamie Ducharme of Boston Magazine writes about a polymer gel being developed by researchers from MIT and Massachusetts General Hospital that could allow for swallowable medical devices. “Improving slow-release safety could open the door for devices that control hunger in obese patients, diagnose gastrointestinal issues, extend the effects of drugs, and more,” Ducharme explains.
MIT researchers have “developed a new ring-like device made of a polymer that can deliver drugs to the stomach over the course of a week,” writes Alexandra Ossola for Popular Science. The team anticipates that the technology could be used for a variety of medical applications.
Scientific American reporter Cynthia Graber speaks with Prof. Sangeeta Bhatia about her new research that shows how bacteria could be used to detect cancer. “I think there's really a whole world of possibilities once you start thinking about using bacteria as a platform upon which to engineer functions,” says Bhatia.
MIT researchers have developed a test that can accurately detect cancer in urine, reports Megan Scudellari for The Boston Globe. “Bacteria can grow in tumors as small as 1 millimeter, so the urine test has the potential to detect liver tumors — which tend to be small and dispersed — very early on, which would improve survival rates for patients,” Scudellari explains.
Professor Sangeeta Bhatia and her colleagues have successfully engineered bacteria that can be used to detect cancer and diabetes, writes Robert Service for Science. The researchers found that “while conventional imaging techniques struggle to detect liver tumors smaller than 1 square centimeter, this approach was able to flag tumors as small as 1 square millimeter.”
Los Angeles Times reporter Melissa Healy writes that researchers from MIT and the University of California, San Diego have successfully modified bacteria to detect cancer. “Their work is a key component of broader efforts to make the diagnosis and treatment of diseases such as cancer increasingly precise and targeted," writes Healy.
Researchers from MIT and the University of California, San Diego have genetically modified bacteria so that it can detect cancer, BBC News reports. The researchers hope that one day, “the general approach could one day be used to develop relatively cheap and easy to use home-testing kits for a range of diseases.”
MIT researchers have developed a non-invasive way to detect liver cancer using probiotics, reports Vijee Venkatraman for BetaBoston. The researchers found that they could “use bacteria as tumor scouts…and engineer them to emit a signal once they reached the mass and multiply.”
Boston.com reporter Dialynn Dwyer writes about how graduate student Steven Keating “fought his cancer with curiosity.” Dwyer explains that Keating “gathered his health data in order to understand the science behind what his body was going through” and even filmed his brain surgery.
Lindsay Kalter reports for The Boston Herald that MIT researchers are developing a device that can be implanted into a tumor to help determine the best course of cancer treatment. “We wanted to bring the laboratory into the human body,” says Langer.
BetaBoston reporter Nidhi Subbaraman writes about how graduate student Steven Keating's thirst for knowledge may have saved his life. After experiencing phantom odors, Keating urged his doctors to perform a brain scan, which revealed a tumor. Since then, Keating has “open-sourced” his illness, and become a “champion of a movement to provide patients with more information about their health.”
Steve Lohr of The New York Times writes about how allowing patients like brain cancer survivor and MIT graduate student Steven Keating greater access to their medical records can not only improve patient health, but also benefit medical research. The sharing of medical records could be a “huge crowdsourcing opportunity for research,” Keating explains.
In a New York Times article, Steve Lohr spotlights how graduate student Steven Keating’s active participation in his medical care led to early detection of a brain tumor. In describing patient access to medical records, Keating explains his belief that “data can heal.”